UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

IBD epidemiology & aetiology

Bel Klaartje Kok, Charles Murray

Summary

AI Generated

This online course covers the epidemiology and aetiology of inflammatory bowel disease, including Crohn's disease and ulcerative colitis, with focus on genetics, the microbiome, and environmental factors.

  • The course explains worldwide incidence and prevalence of Crohn's disease and ulcerative colitis, the two main types of inflammatory bowel disease.
  • Environmental factors, the microbiome, and genetics are thought to contribute to the immune response that culminates in inflammation experienced by patients with IBD.
  • Learning objectives include familiarity with IBD epidemiology, genetic contributions, microbiome role, and environmental factor impacts.
  • The course is suitable for gastroenterologists in training, physicians and surgeons in other disciplines with IBD interest, nurses, biotechnicians, and advanced-years medical students interested in gastroenterology.
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Crohn’s disease and ulcerative colitis — the two main types of inflammatory bowel disease (IBD) — are chronic, relapsing disorders that have a significant impact at both the individual and societal level. 

This online course explains current knowledge on the epidemiology and aetiology of IBD. Authors Klaartje Bel Kok and Charles Murray highlight what is known about the worldwide incidence and prevalence of Crohn’s disease and ulcerative colitis, and how environmental factors, the microbiome and genetics are thought to contribute to the immune response that culminates in the inflammation experienced by patients with IBD. 
 

Learning objectives

To become familiar with:

  • The epidemiology of inflammatory bowel disease (IBD)
  • The contribution of genetics to IBD
  • The role of the microbiome in IBD
  • The impact of environmental factors on IBD

Target audience

This course is suitable for gastroenterologists in training, but it is also appropriate for physicians and surgeons in other disciplines who have an interest in IBD, as well as nurses, biotechnicians and advanced-years’ medical students who have an interest in gastroenterology. 

Reviewed & updated July 2022

Event

IBD epidemiology & aetiology

Topics

IBD

Accreditation status

accredited

Duration

50 minutes

Published

2020

More Like This:

Nutritional aspects: How to provide baseline therapy

Nutritional aspects: How to provide baseline therapy

Julia Mader Julia Mader

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

Yichen Wang Yichen Wang, Brian Lacy, David Cangemi, Li Liu, Elizabeth Lees, Abigail Fickel, Qiyang Pan, Yan Yan, Chenyu Sun, Yuting Huang

Infectious Colitis

Infectious Colitis

Xavier Aldeguer Mante Xavier Aldeguer Mante, Laia Peries

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

Ali Rezaie Ali Rezaie, Mark Pimentel, Ruchi Mathur, Sepideh Mehravar, Krystyna Houser, Victoria Murray, Angel Trujillo, Juliana Germano, Maria Jesus Millan, Stacy Weitsman, Maritza Sanchez, Ignacio Rivera, Gabriela Laughton, Aida Pirvaram

Epithelial metabolism controlling inflammation in IBD

Epithelial metabolism controlling inflammation in IBD

Konrad Aden Konrad Aden

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

Williams Turpin Williams Turpin, Ken Croitoru, Sun-Ho Lee, Benoît Chassaing, Qilong Li, Alyssa Waslyk, Cathy McShane, Cong Phi Dang, Jeongseok Kim

UEG Presentation
New
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky
Nutritional aspects: How to provide baseline therapy

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Nutritional aspects: How to provide baseline therapy

Julia Mader 1

Affiliations

1 Medizinsiche Universität Graz, Graz, Austria

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Event

UEG Week Barcelona 2026

Topics

Hepatobiliary Small Intestine & Nutrition Mechanisms & Personalised Medicine

Session

Therapy update: Anti-obesity

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

Nutritional aspects: How to provide baseline therapy

Nutritional aspects: How to provide baseline therapy

Julia Mader Julia Mader

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

Yichen Wang Yichen Wang, Brian Lacy, David Cangemi, Li Liu, Elizabeth Lees, Abigail Fickel, Qiyang Pan, Yan Yan, Chenyu Sun, Yuting Huang

Infectious Colitis

Infectious Colitis

Xavier Aldeguer Mante Xavier Aldeguer Mante, Laia Peries

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

Ali Rezaie Ali Rezaie, Mark Pimentel, Ruchi Mathur, Sepideh Mehravar, Krystyna Houser, Victoria Murray, Angel Trujillo, Juliana Germano, Maria Jesus Millan, Stacy Weitsman, Maritza Sanchez, Ignacio Rivera, Gabriela Laughton, Aida Pirvaram

Epithelial metabolism controlling inflammation in IBD

Epithelial metabolism controlling inflammation in IBD

Konrad Aden Konrad Aden

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

Williams Turpin Williams Turpin, Ken Croitoru, Sun-Ho Lee, Benoît Chassaing, Qilong Li, Alyssa Waslyk, Cathy McShane, Cong Phi Dang, Jeongseok Kim

UEG Poster
New
Standard Poster
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

Yuting Huang 1, Chenyu Sun 2, Yichen Wang 1, Yan Yan 1, Qiyang Pan 2, Abigail Fickel 2, Elizabeth Lees 2, Li Liu 3, David Cangemi 1, Brian Lacy 1

Affiliations

1 Mayo Clinic, Jacksonville, United States

2 Mayo Clinic, Rochester, United States

3 The Second People’s Hospital of Hefei, Hefei, China

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Ehlers-Danlos syndrome (EDS) is a heterogeneous group of connective tissue disorders characterized by collagen abnormalities that frequently involve the gastrointestinal tract. Patients with EDS commonly report symptoms consistent with disorders of gut-brain interaction, including irritable bowel syndrome (IBS); however, population-level evidence quantifying this association remains limited. Furthermore, psychological comorbidities such as anxiety are highly prevalent in EDS and may contribute to gastrointestinal symptom development, yet their potential mediating role in the relationship between EDS and IBS has not been well characterized. We therefore conducted a large national inpatient database analysis to evaluate the association between EDS and IBS and to explore the contribution of anxiety as a potential mediator.

Aims & Methods

We performed a retrospective study using the 2019 National Inpatient Sample (NIS) database to identify hospitalizations involving EDS and IBS using ICD-10 diagnostic codes, including hypermobility spectrum disorder classifications. Demographic characteristics, comorbidities, and socioeconomic variables were analyzed. Multivariable logistic regression models were constructed to evaluate the association between EDS and IBS while adjusting for potential confounders. Subgroup analyses were performed according to IBS subtype. Structural equation modeling (SEM) was applied to assess anxiety as a mediator between EDS and IBS. Statistical analyses were conducted using Stata 15.1 and R 4.5.2.

Results

An estimated 35,419,023 hospitalizations were analyzed, including 14,675 EDS cases and 320,635 IBS cases. Patients with EDS were younger (mean age 36.2 vs. 50.2 years), predominantly female (84.8% vs. 55.8%), and demonstrated higher prevalence of psychiatric and gastrointestinal comorbidities. EDS was strongly associated with IBS across regression models, with odds ratios (ORs) of 7.66 (95% CI: 6.56 - 8.95) in crude analysis, 5.80 (95% CI: 4.92 - 6.83) after adjustment for demographics and socioeconomic factors, 4.96 (95% CI: 4.20 - 5.86) after inclusion of gastrointestinal and psychiatric diagnoses, and 4.16 (95% CI: 3.50 - 4.93) in the fully adjusted model. The strongest association was observed for IBS with constipation (OR 7.80, 95% CI: 5.19 - 11.71), followed by mixed subtype (OR 5.34, 95% CI: 2.35 - 12.15) and unspecified IBS (OR 3.57, 95% CI: 2.92 - 4.36). Anxiety was present in 36.16% of IBS and 32.65% of EDS cases. SEM analysis demonstrated that anxiety partially mediated the EDS-IBS relationship, accounting for approximately 6.6% of the total effect, while the majority of the association remained attributable to direct effects.

Conclusion

EDS is strongly associated with IBS, particularly constipation-predominant disease, in a large national inpatient cohort. Anxiety partially mediates this relationship but does not fully explain the observed association, suggesting that connective tissue abnormalities and altered gut-brain signaling may independently contribute to IBS pathophysiology in EDS. These findings highlight the importance of integrated gastrointestinal and psychological assessment in patients with EDS and support increased clinical awareness of IBS risk within this population. Future prospective studies are needed to clarify mechanistic pathways and optimize multidisciplinary management strategies for disorders of gut-brain interaction in connective tissue disease.

References

1. Yew, K.S., K.A. Kamps-Schmitt, and R. Borge, Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders. Am Fam Physician, 2021. 103(8): p. 481-492.
2. Thwaites, P.A., P.R. Gibson, and R.E. Burgell, Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know. J Gastroenterol Hepatol, 2022. 37(9): p. 1693-1709.
3. Ishiguro, H., H. Yagasaki, and Y. Horiuchi, Ehlers-Danlos Syndrome in the Field of Psychiatry: A Review. Front Psychiatry, 2021. 12: p. 803898.
4. Fakhfouri, G., N.R. Mijailović, and R. Rahimian, Psychiatric Comorbidities of Inflammatory Bowel Disease: It Is a Matter of Microglia's Gut Feeling. Cells, 2024. 13(2).
5. https://icd.who.int/browse10/2019/en.
6. https://hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp.
7. Tomarken, A.J. and N.G. Waller, Structural equation modeling: strengths, limitations, and misconceptions. Annu Rev Clin Psychol, 2005. 1: p. 31-65.

Conference

UEG Week Barcelona 2026

Topics

Colorectal

Submission format

Abstract

Session

LOWER GI (EXCLUDING IBD) (Posters)

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

Nutritional aspects: How to provide baseline therapy

Nutritional aspects: How to provide baseline therapy

Julia Mader Julia Mader

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

Yichen Wang Yichen Wang, Brian Lacy, David Cangemi, Li Liu, Elizabeth Lees, Abigail Fickel, Qiyang Pan, Yan Yan, Chenyu Sun, Yuting Huang

Infectious Colitis

Infectious Colitis

Xavier Aldeguer Mante Xavier Aldeguer Mante, Laia Peries

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

Ali Rezaie Ali Rezaie, Mark Pimentel, Ruchi Mathur, Sepideh Mehravar, Krystyna Houser, Victoria Murray, Angel Trujillo, Juliana Germano, Maria Jesus Millan, Stacy Weitsman, Maritza Sanchez, Ignacio Rivera, Gabriela Laughton, Aida Pirvaram

Epithelial metabolism controlling inflammation in IBD

Epithelial metabolism controlling inflammation in IBD

Konrad Aden Konrad Aden

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

Williams Turpin Williams Turpin, Ken Croitoru, Sun-Ho Lee, Benoît Chassaing, Qilong Li, Alyssa Waslyk, Cathy McShane, Cong Phi Dang, Jeongseok Kim

UEG Online Course
not accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Infectious Colitis

Laia Peries, Xavier Aldeguer Mante

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Infectious colitis is a highly prevalent condition and a major cause of morbidity worldwide. Clinical management of infectious colitis, which can be caused by various intestinal pathogens and some sexually transmitted pathogens, is a medical challenge.

This online course provides the latest information on all aspects of infectious colitis. Authors Laia Peries and Xavier Aldeguer discuss the aetiology, epidemiology, symptoms and clinical features. They describe the general diagnostic approach to infectious colitis and present a diagnostic algorithm. They also summarize the treatment options and raise awareness of complications and special situations.

Learning objectives

  • To understand how to reach a conclusive diagnosis of GORD
  • To know how to reach a conclusive diagnosis of no GORD
  • To understand how to deal with an inconclusive diagnosis

Target audience

This course is suitable for gastroenterologists in training, but it is also appropriate for physicians and surgeons in other disciplines who have an interest in infectious colitis, as well as nurses, biotechnicians and advanced-years’ medical students who have an interest in gastroenterology. 

Event

Infectious Colitis

Topics

Small Intestine & Nutrition

Accreditation status

not accredited

Duration

1 hour

Published

2021

More Like This:

Nutritional aspects: How to provide baseline therapy

Nutritional aspects: How to provide baseline therapy

Julia Mader Julia Mader

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

Yichen Wang Yichen Wang, Brian Lacy, David Cangemi, Li Liu, Elizabeth Lees, Abigail Fickel, Qiyang Pan, Yan Yan, Chenyu Sun, Yuting Huang

Infectious Colitis

Infectious Colitis

Xavier Aldeguer Mante Xavier Aldeguer Mante, Laia Peries

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

Ali Rezaie Ali Rezaie, Mark Pimentel, Ruchi Mathur, Sepideh Mehravar, Krystyna Houser, Victoria Murray, Angel Trujillo, Juliana Germano, Maria Jesus Millan, Stacy Weitsman, Maritza Sanchez, Ignacio Rivera, Gabriela Laughton, Aida Pirvaram

Epithelial metabolism controlling inflammation in IBD

Epithelial metabolism controlling inflammation in IBD

Konrad Aden Konrad Aden

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

Williams Turpin Williams Turpin, Ken Croitoru, Sun-Ho Lee, Benoît Chassaing, Qilong Li, Alyssa Waslyk, Cathy McShane, Cong Phi Dang, Jeongseok Kim

UEG Presentation
New
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky
EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

Aida Pirvaram 1, Gabriela Laughton 1, Ignacio Rivera 1, Maritza Sanchez 1, Stacy Weitsman 1, Maria Jesus Millan 1, Juliana Germano 1, Angel Trujillo 1, Victoria Murray 1, Krystyna Houser 2, Sepideh Mehravar 1, Ruchi Mathur 1,3, Mark Pimentel 1,4, Ali Rezaie 1,5

Affiliations

1 Medically Associated Science and Technology (MAST) Program, Cedar-Sinai, Los Angeles, CA, Los Angeles, United States

2 mBiota Elemental, Sana Monica, Los Angeles, United States

3 Division of Endocrinology, Diabetes and Metabolism. Department of Medicine, Cedar -Sinai, Los Angeles, CA., Los Angeles, United States

4 Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedar -Sinai, Los Angeles, CA, Los Angeles, United States

5 Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedar-Sinai, Los Angeles, CA, Los Angeles, United States

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Elemental diets (EDs) are nutritionally complete formulations used in gastrointestinal disorders, consisting of low fat content, free amino acids, easily absorbable carbohydrates, and micronutrients. We have previously shown in a human trial that eucaloric palatable ED (PED) induces weight loss with preferential fat reduction and relative preservation of lean mass (Rezaie et al., 2025). We therefore evaluated the impact of PED on body composition in controlled lean and obese murine models.

Aims & Methods

Five groups of 8–10-week-old male mice (n=5 per group) were studied. After 4 days of acclimation, mice were randomized to 14 days of dietary intervention: lean mice (C57BL/6J) to chow or PED (mBIOTA Elemental, US), and obese mice (C57BL/6J DIO, pre-conditioned on high-fat diet [HFD; Research Diets, US]) to PED, chow (LabDiet, US), or continued HFD.
Body weight was recorded at baseline and day 14 along with microCT imaging (Revvity, USA) of the abdomen and pelvis to quantify visceral fat, subcutaneous fat, total fat, and muscle volume. CT images were analyzed using Analyze 15.0 with standardized segmentation. Paired two-tailed t-tests and one-way ANOVA with Bonferroni correction were used.

Results

In lean mice groups, PED led to a trend toward weight loss (27.1±1.0, 23.9±3.4 g, p=0.052). This was accompanied by reductions in total fat (2461±603 to 1778±930 mm³, p = 0.01) and subcutaneous fat (1294±367 to 892±392 mm³, p=0.005). (Table) Visceral fat decreased numerically (1074± 244 to 791± 542 mm³, p=0.18), while muscle mass was preserved (5149±460 to 5471±503 mm³, p=0.21).

In contrast, chow-fed lean mice did not lose weight (27.2±1.4 to 27.2±1.3 g, p 0.98) and demonstrated an increase in visceral fat (689±101 to 1068±256 mm³, p=0.03), with no significant change in total fat (1808±351.2 to 2245±330.5 mm³,p=0.12) or muscle mass (5467±705.7 to 5385 ± 479.4 mm³, p=0.34). As compared to regular chow, PED in lean mice resulted in greater changes in visceral fat (−282 to +379 mm³, p =0.009) and total fat (−683 to +437 mm³, p< 0.01), with a trend toward reduced subcutaneous fat (p=0.06) and no difference in muscle mass (p=0.39).

Obese mice transitioning from HFD to PED exhibited transient reductions in food intake initially. Continued HFD resulted in weight gain (33.6±2.5 to 35.0±3.2 g, p=0.04). Switching to chow induced weight loss (34.6±2.4 to 30.5±1.5 g, p=0.0065) with reductions in visceral (p=0.001), subcutaneous (p=0.01), and total fat (p=0.004), and increased muscle mass (p=0.02). PED induced marked weight loss (35.4±1.0 to 23.2±2.4 g, p<0.01) with profound reductions in visceral, subcutaneous, and total fat (all p<0.001) and reduced muscle mass (p=0.004). Weight loss was predominantly driven by reductions in adipose tissue.

Table. Abdominal fat and mid-body muscle mass in lean and obese mice before and after 14 days of dietary intervention.

Group
Total fat (Baseline)
(mm³, mean ± SD)
Total fat (Day 14)
(mm³, mean ± SD)
Visceral fat (Baseline)
(mm³, mean ± SD)
Visceral fat (Day 14)
(mm³, mean ± SD)
Subcutaneous fat (Baseline)
(mm³, mean ± SD)
Subcutaneous fat (Day 14)
(mm³, mean ± SD)
Muscle mass (Baseline)
(mm³, mean ± SD)
Muscle mass (Day 14)
(mm³, mean ± SD)
Lean-PED
2461±603.7
1778 ± 930.1*
1074 ± 244.3
791.2 ± 542.4
1294 ± 367.1
892.8 ± 392.8*
5149 ± 460.2
5471 ± 503.8
Lean-Chow
1808 ± 351.2
2245 ± 330.5
689.1 ± 101.8
1068 ± 256.8*
1015 ± 339.6
1099 ± 110.9
5467 ± 705.7
5385 ± 479.4
Obese-PED
7392 ± 1239
2245 ± 954.4*
3334 ± 746.6
938.6 ± 536.2*
3956 ± 596.3
1226 ± 464.0*
5733 ± 476.3
4743 ± 384.7*
Obese-Chow
6724 ± 1752
3481 ± 709.9*
3087 ± 759.3
1539 ± 415.4*
3542 ± 997.1
1876 ± 401.0*
5414 ± 356.3
5823 ± 275.5*
Obese-HFD
6080 ± 1166
6647 ± 1334
2788 ± 397.8
2852 ± 757.6
3202 ± 792.9
3721 ± 769.0
5420 ± 425.3
5784 ± 629.6
* p < 0.05 vs baseline (paired t-test)

Conclusion

PED induces rapid and pronounced reductions in visceral and subcutaneous adipose tissue. Weight reductions are fat-predominant, with preservation of muscle in lean mice and modest muscle loss during early adaptation in obese mice. Together with prior human data, these findings support a preferential effect of elemental nutrition on adipose tissue. Further mechanistic studies are warranted.

References


Rezaie et al. Clinical Gastroenterology and Hepatology.2025
https://doi.org/10.1016/j.cgh.2025.03.002

Disclosure

Ali Rezaie is a consultant/speaker for Bausch Health; and has equity in Alimetry, Gemelli Biotech, and Good LFE.
Ruchi Mathur has equity in Gemelli Biotech and Good LFE.
Krystyna Houser has equity in Good LFE. Mark Pimentel is a consultant for Ferring Pharmaceuticals, Inc, Salvo Health, and Vivante Health, Inc; has received grant support from Bausch Health; and has equity in Gemelli Biotech, Salvo Health, Vivante Health, and Good LFE.
The remaining authors disclose no conflicts.

Event

UEG Week Barcelona 2026

Topics

Surgery Small Intestine & Nutrition Endoscopy

Submission format

Abstract

Session

Nutrition, metabolism and the therapeutics of obesity

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

Nutritional aspects: How to provide baseline therapy

Nutritional aspects: How to provide baseline therapy

Julia Mader Julia Mader

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

Yichen Wang Yichen Wang, Brian Lacy, David Cangemi, Li Liu, Elizabeth Lees, Abigail Fickel, Qiyang Pan, Yan Yan, Chenyu Sun, Yuting Huang

Infectious Colitis

Infectious Colitis

Xavier Aldeguer Mante Xavier Aldeguer Mante, Laia Peries

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

Ali Rezaie Ali Rezaie, Mark Pimentel, Ruchi Mathur, Sepideh Mehravar, Krystyna Houser, Victoria Murray, Angel Trujillo, Juliana Germano, Maria Jesus Millan, Stacy Weitsman, Maritza Sanchez, Ignacio Rivera, Gabriela Laughton, Aida Pirvaram

Epithelial metabolism controlling inflammation in IBD

Epithelial metabolism controlling inflammation in IBD

Konrad Aden Konrad Aden

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

Williams Turpin Williams Turpin, Ken Croitoru, Sun-Ho Lee, Benoît Chassaing, Qilong Li, Alyssa Waslyk, Cathy McShane, Cong Phi Dang, Jeongseok Kim

UEG Presentation
New
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky
Epithelial metabolism controlling inflammation in IBD

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Epithelial metabolism controlling inflammation in IBD

Konrad Aden 1

Affiliations

1 IKMB + First Medical Department, Kiel, Germany

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Event

UEG Week Barcelona 2026

Topics

Small Intestine & Nutrition Mechanisms & Personalised Medicine Immunology IBD

Session

Metabolic aspects of immunomodulatory IBD therapy

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

Nutritional aspects: How to provide baseline therapy

Nutritional aspects: How to provide baseline therapy

Julia Mader Julia Mader

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

Yichen Wang Yichen Wang, Brian Lacy, David Cangemi, Li Liu, Elizabeth Lees, Abigail Fickel, Qiyang Pan, Yan Yan, Chenyu Sun, Yuting Huang

Infectious Colitis

Infectious Colitis

Xavier Aldeguer Mante Xavier Aldeguer Mante, Laia Peries

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

Ali Rezaie Ali Rezaie, Mark Pimentel, Ruchi Mathur, Sepideh Mehravar, Krystyna Houser, Victoria Murray, Angel Trujillo, Juliana Germano, Maria Jesus Millan, Stacy Weitsman, Maritza Sanchez, Ignacio Rivera, Gabriela Laughton, Aida Pirvaram

Epithelial metabolism controlling inflammation in IBD

Epithelial metabolism controlling inflammation in IBD

Konrad Aden Konrad Aden

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

Williams Turpin Williams Turpin, Ken Croitoru, Sun-Ho Lee, Benoît Chassaing, Qilong Li, Alyssa Waslyk, Cathy McShane, Cong Phi Dang, Jeongseok Kim

UEG Presentation
New
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky
CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

Jeongseok Kim 1, Cong Phi Dang 2, Cathy McShane 1, Alyssa Waslyk 1, Qilong Li 1, Benoît Chassaing 3, Sun-Ho Lee 1,2, Ken Croitoru 1,2, Williams Turpin 1,2

Affiliations

1 Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada

2 Temerty Faculty of Medicine, University of Toronto, Toronto, Canada

3 Institut Pasteur, Université Paris Cité, INSERM U1306, Paris, France

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Crohn’s disease (CD) is a chronic disorder of unknown etiology. Diet, particularly the consumption of ultra-processed foods (UPFs), has been implicated in CD development. Despite this, there is limited research examining how UPFs influence the mucosal immune response. Our study aims to (i) determine whether long-term UPF consumption alters the inflammatory potential of the gut microbiome and (ii) assess whether transfer of the microbiome from individuals consuming high amounts of UPFs affects intestinal T-cell populations in germ-free mice (GFMs).

Aims & Methods

Serum and stool samples collected prior to the onset of CD were obtained from the GEM project, a cohort of prospectively followed healthy first-degree relatives of CD patients. The microbiome was characterized by 16S rRNA sequencing of stool DNA, and serum protein profiles were measured using the Olink Proximity Extension Assay. For mouse experiments, human feces from high- or low-UPF consumers, defined as individuals with more than 40% of daily caloric intake derived from NOVA4 food items according to the NOVA classification, were transplanted into wild-type germ-free recipient mice fed either a standard chow diet or a Western diet. After four weeks of microbial colonization, lamina propria T-cell populations in the intestine, including RORγt⁺ Treg (CD4⁺RORγt⁺FoxP3⁺) and Th17 (CD4⁺RORγt⁺FoxP3⁻) cells, were analyzed using flow cytometry.

Results

Our study included 2,336 participants, including 1,977 from Canada and 359 from the United States. The mean proportion of total energy consumption from UPFs was 36.6 ±12.7%. Participants with higher UPF consumption showed significant difference in 36 serum proteins (q<0.007) compared with those with lower UPF consumers. Notably, immune-related proteins, including IL2RA, TNFRS9, TNFRSF11A, and CD4, were enriched in individuals with high UPF consumption. Microbiome analysis revealed that several taxa, predominantly from the Lachnospiraceae and Ruminococcaceae families, were associated with UPF consumption. In addition, the presence of Marvinbryantia was associated with an increased risk of CD among individuals with high UPF consumption. Mice receiving feces from high-UPF consumers exhibited reduced proportion of protective RORyt⁺ Treg cells in both the ileum and colon (p<0.001). Moreover, mice fed a Western diet (high in fat and simple sugars) and colonized with feces from high-UPF consumer showed a significantly higher proportion of Th17 cells in the colon than mice receiving feces from low-UPF consumers (p=0.023).

Conclusion

Our findings suggest that UPF consumption alters the inflammatory potential of the gut microbiome. Using gnotobiotic mice, we further demonstrated that UPF-associated microbial communities may induce an imbalance between RORγt⁺ regulatory T cells and Th17 cells. Together, these results suggest that the gut microbiome associated with high UPF consumption may contribute to CD onset through immune dysregulation and support the notion that dietary modulation of the microbiome could represent a potential strategy for CD prevention.

Disclosure

On half of the CCC-GEM Project Research Consortium
Funding agencies: CCC, CIHR, and Helmsley Charitable trust

Event

UEG Week Barcelona 2026

Topics

IBD Mechanisms & Personalised Medicine Immunology Gut Microbiota Small Intestine & Nutrition

Submission format

Abstract

Session

On bugs and food: New lessons in microbiomics and dietomics in IBD

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

Nutritional aspects: How to provide baseline therapy

Nutritional aspects: How to provide baseline therapy

Julia Mader Julia Mader

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

EHLERS-DANLOS SYNDROME AND ITS ASSOCIATION WITH IRRITABLE BOWEL SYNDROME: A 2019 NATIONAL INPATIENT SAMPLE-BASED ANALYSIS

Yichen Wang Yichen Wang, Brian Lacy, David Cangemi, Li Liu, Elizabeth Lees, Abigail Fickel, Qiyang Pan, Yan Yan, Chenyu Sun, Yuting Huang

Infectious Colitis

Infectious Colitis

Xavier Aldeguer Mante Xavier Aldeguer Mante, Laia Peries

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

EFFECTS OF EXCLUSIVE PALATABLE ELEMENTAL DIET ON BODY COMPOSITION IN OBESE AND LEAN MICE

Ali Rezaie Ali Rezaie, Mark Pimentel, Ruchi Mathur, Sepideh Mehravar, Krystyna Houser, Victoria Murray, Angel Trujillo, Juliana Germano, Maria Jesus Millan, Stacy Weitsman, Maritza Sanchez, Ignacio Rivera, Gabriela Laughton, Aida Pirvaram

Epithelial metabolism controlling inflammation in IBD

Epithelial metabolism controlling inflammation in IBD

Konrad Aden Konrad Aden

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

CONSUMPTION OF ULTRA-PROCESSED FOOD PROMOTE INFLAMMATORY POTENTIAL OF FECAL MICROBIOME THROUGH ALTERING THE BALANCE OF TH17 AND RORYT TREG

Williams Turpin Williams Turpin, Ken Croitoru, Sun-Ho Lee, Benoît Chassaing, Qilong Li, Alyssa Waslyk, Cathy McShane, Cong Phi Dang, Jeongseok Kim

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.